Algeness is a patented family of fully resorbable injectable gel implant dermal fillers that are 100% natural.

Advanced Aesthetic Technologies, Inc. (AAT) and Algeness are finalists in the recent Terra2 Solutions Skin Health Innovation Competition.

Algeness is a patented family of fully resorbable injectable gel implant dermal fillers that are 100% natural and based on purified agarose with a differentiated clinical and safety performance profile. Algeness holds a CE Mark and is currently distributed in more than 30 countries worldwide. AAT has begun efforts to obtain US FDA approval.

Gore Range Capital partnered with Terra2 Solutions and DermX Media Group to host the Terra2 Solutions Skin Health Innovation Competition. The finals were held during the 18th Annual Winter Clinical Dermatology Conference-Hawaii (WC21).

 “We were very honored that Algeness was invited to participate in this prestigious competition, pleased to be initially selected as one of the top four semifinalists to present during WC21, and delighted to finish as one of the top two as selected by a group of industry leaders and highly respected physicians,” says Doug Abel, CEO of AAT, in a news release. “This notable recognition from potential customers and investors underscores the unique advantages of the Algenesstechnology as a differentiator in the global dermal filler market.”

Participating companies presented to a panel of judges and providers in the fields of clinical dermatology, aesthetic medicine, and other aspects of skin health, and executive leaders of pharmaceutical, medical device, diagnostic, and IT companies. Four semifinalists including AAT presented their pitch videos to the entire audience during the meeting, and the two finalists, AAT and Mindera Corporation, were given the opportunity to present a live pitch to be followed by questions from the panel of judges. 

“The dermal filler market is one of the most attractive segments in healthcare. Advanced Aesthetic Technologies has the know-how, the assets, and the capabilities necessary to bring innovative and differentiated products to this market. The recent Terra2 Solutions Skin Health Competition recognized AAT’s Algeness as a finalist among the most innovative technologies in medical skin health in the world,” says Humberto Antunes, Founder of Terra2 Solutions, a Partner at Gore Range, and former global CEO of Galderma Laboratories

“The unique attributes of Algenessas presented will provide an important addition to the dermal filler market, filling a need for a product that offers a differentiated capability for achieving facial shape and contour definition and the potential for an outstanding safety profile," says dermatologist Valerie Callender, MD, FAAD, of Callender Dermatology and Cosmetic Center in Glenn Dale, MD, who served as one of the judges.